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Abstract 
Background: The relationship between alcohol consumption and liver cirrhosis mortality has been revealed by data 
from several different countries. However, the impact of tobacco smoking on liver cirrhosis has not been considered. 
The aim of this study was to estimate trends in liver cirrhosis mortality and alcohol and tobacco consumption from 
1952 to 2013 as well as more recent trends in substance use disorder treatments and hospital treatments of liver 
diseases in Germany.
Methods: Data from the National Statistics Office were used. Liver cirrhosis was diagnosed according to the Interna-
tional Classification of Diseases (ICD-6 to ICD-10). Alcohol beverages and tobacco products were estimated according 
to tax or governmental data. Substance use disorder treatment and hospital treatment data were used. Trends were 
calculated using Joinpoint regression analyses.
Results: Liver cirrhosis mortality among men increased annually by 8.4 % from 1952 to 1960 and increased annually 
by 2.8 % from 1961 to 1976. From 1976 to 1982, liver cirrhosis mortality decreased annually by 4.8 %, from 1982 to 
2013 liver cirrhosis mortality decreased annually by 1.2 %. Among females, liver cirrhosis mortality increased annually 
by 8.9 % from 1952 to 1959 and by 4.3 % from 1959 to 1968, but then decreased 1.0 % annually from 1968 to 1995. 
After 1995, liver cirrhosis mortality decreased 1.9 % annually through 2013. These reductions in liver cirrhosis mortality 
were accompanied by decreases in alcohol consumption beginning in 1976. These findings were also accompanied 
by decreases in the consumption of cigarette equivalents since 1971. Meanwhile, the number of substance use disor-
der treatments and hospital treatments of liver diseases increased.
Conclusions: The decrease in liver cirrhosis mortality may have been caused by a decrease in alcohol drinking 
and tobacco smoking. Smoking may have exerted indirect effects via alcohol consumption as well as direct effects. 
These trends existed despite largely missing preventive efforts to reduce alcohol consumption and tobacco smoking. 
Increases in educational attainment in the general population may have contributed to the reductions in alcohol and 
tobacco consumption. Convincing evidence that the increased provision of substance use disorder treatment signifi-
cantly contributed to the decrease of liver cirrhosis was not found.
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Background
Worldwide, liver cirrhosis mortality has decreased since 
the mid-1970s [1]. For European countries, liver cirrho-
sis mortality increased from 1959 until the 1970s but 
was subsequently followed by a decrease in liver cirrho-
sis mortality [2]. In the United States, similar trends have 
been found [3].
The relationship between liver cirrhosis mortality and 
alcohol consumption has been identified in data col-
lected from several countries [4, 5], including decreases 
in liver cirrhosis mortality after preventive efforts to 
reduce alcohol consumption [6]. Dose–response rela-
tionships between alcohol consumption and liver cirrho-
sis mortality also exist [7]. Latencies in the time between 
changes in alcohol consumption and rates of liver cir-
rhosis mortality of less than 1 year have been found [8]. 
Potential reasons for decreases in liver cirrhosis mortality 
can be analyzed using a time trends study design utiliz-
ing alcohol tax data. This approach has the advantage of 
introducing only a small amount of bias compared with 
estimates of alcohol consumption using national survey 
data. These surveys, estimated using alcohol production 
data, have been shown to disclose just 40–60  % of true 
alcohol consumption [9].
One limitation of time-trend analysis studies is that 
previously tobacco smoking had not been considered as 
having an impact on liver cirrhosis through alcohol con-
sumption. Because alcohol consumption and smoking 
have been found to be interrelated [10] smoking might 
contribute to sustaining a high level of alcohol consump-
tion, thereby indirectly increasing the risk of liver cirrho-
sis. Additionally, direct relationships between smoking 
and liver cirrhosis exist. In a population cohort study, 
among those who smoked 11 or more grams of tobacco 
per day, women had a hazard ratio of 2.2 (1.4–3.4) for 
liver cirrhosis and men had a hazard ratio of 1.4 (0.9–2.2) 
for liver cirrhosis compared to female and male never 
smokers after adjustment for alcohol consumption, 
respectively [11]. Twelve percent of liver cirrhosis cases 
among women and 6  % of liver cirrhosis cases among 
men have been attributed to smoking [11]. In a sample 
of 1,290,413 women smoking was predictive for liver 
disease after 6  years [12]. Despite drinking less than 50 
grams of pure alcohol per week, women had a relative 
risk of 2.9 (2.4–3.5) for liver cirrhosis if they were cur-
rent smokers [12]. Female smokers who drank 50 grams 
or more of pure alcohol per week, had a relative risk for 
liver cirrhosis of 8.0 (6.8–9.4) compared to female non-
smokers who drank less than 50 grams of pure alcohol 
per week. There was a dose–response relationship among 
women who consumed 50 g or more of pure alcohol per 
week: the more the women smoked, the higher their rela-
tive risk of liver cirrhosis [12].
The aim of this paper is to first analyze trends of liver 
cirrhosis mortality and alcohol consumption in Germany 
over a 62 year period through the year 2013. Second, trends 
in tobacco use will be analyzed, and a correspondence of 
tobacco use with liver cirrhosis mortality will be estimated. 
Third, more recent trends of the number of substance use 
disorder (SUD) treatments provided and hospital treat-
ments for alcohol-related liver disease will be analyzed.
Methods
Data sources
Annual data concerning liver cirrhosis mortality, 
amounts of alcohol and taxed tobacco products, were 
provided for each year from 1952 to 2013, data about 
treatments of SUD for 1982–2013, and data about hos-
pital treatments of liver diseases for 2000–2013 by the 
National Statistics Office for the Federal Republic of 
Germany. Until 1990 the data were collected from West 
Germany only, from 1991 to 2013 the data were collected 
from all of Germany. Because of the German reunifica-
tion no data for the year 1990 were available. We used 
the mean of 1989 and 1991 for the year 1990. All data are 
standardized to Germans based on the national popula-
tion of those who were of drinking and smoking age (15 
or older). If possible data were stratified by sex.
For the estimation of deaths from liver cirrhosis, we 
used the causes of death statistics from the Federal 
Republic of Germany. Amounts of alcohol were provided 
by tax or governmental data as liters of beer or wine pro-
duced minus exports, plus imports (only exception: beer 
from countries outside the European Union). The pro-
portion of pure alcohol for beer was calculated as 4.8 % 
alcohol per volume. Non-alcoholic beer from 1993 on 
was excluded from the tax statistics. The proportion of 
pure alcohol for wine or sparkling wine was calculated 
as 11.0  % alcohol per volume [13]. The amount of pure 
alcohol in spirits was provided by the producers via tax 
authorities to the National Statistics Office. Tobacco tax 
statistics from the National Statistics Office provided the 
number of cigarettes, number of cigars or small cigars, 
tons of fine-cut tobacco, and tons of pipe tobacco for each 
year between 1952 and 2013 [19, 20]. For the calculation 
of the number of SUD treatments data were provided 
by the institution that finances these treatments (Ger-
man Pension Insurance). SUD included alcohol depend-
ence and drug dependence. In the years 2003–2013, 
67–74 % of the male and 76–81 % of the female patients 
were treated for alcohol dependence [14]. The number of 
SUD treatments in Germany has been documented since 
1982. We used the data for each year from 1982 to 2013. 
Hospital inpatient diagnoses at discharge were provided 
according to the International Classification of Diseases 
(ICD; codes with 3 digits).
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Outcomes
For liver cirrhosis mortality the diagnosis “liver cirrhosis” 
was identified according to ICD-6, code 581, for the years 
1952–1957, according to ICD-7, code 581, for the years 
1958–1967, according to ICD-8, code 571, for the years 
1968–1978, according to ICD-9, code 571.2, alcoholic 
liver cirrhosis, and 571.5, liver cirrhosis with alcohol not 
specified, for the years 1979–1997, and according to ICD-
10, code K70.3, alcohol liver cirrhosis, and K74.6, other 
or unspecified liver cirrhosis, for the years 1998–2013.
Alcohol consumption was estimated as the amount of 
pure alcohol divided by the population at age 15 or older 
for each year [9]. Cigarette equivalents were used to esti-
mate tobacco smoked per year. Number of cigars or small 
cigars, tons of fine-cut tobacco and tons of pipe tobacco 
were converted to cigarette equivalents using one gram 
of fine-cut or pipe tobacco as one cigarette equivalent 
and one cigar or small cigar as two cigarette equivalents 
according to standard conventions of the Organization for 
Economic Co-operation and Development [21]. For SUD 
treatments, we used the number of SUD treatments given 
per year. This treatment is provided as both an inpatient 
or outpatient service, with the aim of supporting patients 
in achieving long-term abstinence. For hospital treatments 
of liver diseases inpatient diagnoses we used the ICD-
10-diagnosis groups K70 and K74 from 2000 onwards. K70 
includes alcoholic liver diseases: fatty liver, hepatitis, fibro-
sis and sclerosis, cirrhosis, and liver failure. K74 includes 
non-alcohol-related fibrosis and cirrhosis of the liver.
Ethical considerations
The study adheres to the STROBE statement (http://
www.strobe-statement.org).
Statistical analysis
Trends were calculated using Joinpoint regression analy-
ses according to the program Joinpoint 4.1.1.3 [15]. It 
provides begin and end of single trends. Annual per-
cent changes as a measure of the strength of a trend are 
reported. Insignificant annual percent changes were inter-
preted as stable. For liver cirrhosis mortality, alcohol, and 
cigarette equivalents, we defined a maximum number of 
four trends. At a maximum, two trends were allowed both 
for SUD treatments and hospital treatments, due to the 
few number of years available for analysis.
Availability of supporting data
All data used in the Joinpoint analyses are provided in 
Additional files 1, 2 and 3.
Results
Liver cirrhosis mortality increased from 1952 to 51.4 per 
100,000 men and 21.4 per 100,000 women aged 15 or 
older in 1976. In 2013 liver cirrhosis mortality was 26.2 
per 100,000 men and 12.3 per 100,000 women aged 15 or 
older. Among men, trend analyses revealed that liver cir-
rhosis mortality increased annually by 8.4 % from 1952 to 
1960 and annually by 2.8 % from 1960 to 1976. From 1976 
to 1982 liver cirrhosis mortality decreased annually by 
4.8 %, after 1982 liver cirrhosis mortality decreased annu-
ally by 1.2 % until 2013 (Table 1; Fig. 1). Among females, 
liver cirrhosis mortality increased annually by 8.9 % from 
1952 to 1959 and by 4.3  % annually from 1959 to 1968. 
Liver cirrhosis mortality then decreased by 1.0 % annually 
until the year 1995, at which point liver cirrhosis mortality 
decreased by 1.9 % annually until 2013. The ratio of liver 
cirrhosis mortality for men to women remained constant 
from 1952 to 2013 and ranged from 2.1 to 2.3.
Alcohol consumption increased until 1976 but then 
decreased from 1,661,924 liters per 100,000 population 
aged 15 or older in 1976 to 1,391,211 liters in 1986 and 
1,112,716  liters in 2013. Trend analysis revealed that 
alcohol consumption from 1952 to 1962 increased annu-
ally by 7.9 percentage points; from 1962 to 1971, alcohol 
consumption increased annually by 3.4  %. In 1971 con-
sumption leveled off until 1976, and beginning in 1976 
consumption decreased annually by 1.0 % until 2013.
The number of cigarette equivalents per 100,000 popu-
lation aged 15 or older was 292 million in 1971 and 163 
million in 2013. The consumption of cigarette equivalents 
increased annually by 3.6 % from 1952 to 1971, and after 
1971 decreased annually by 0.9 % until 2003. After 2003, 
cigarette equivalents consumption remained unchanged 
until 2013.
The number of SUD treatments increased from 32.7 per 
100,000 in 1982 to 81.2 per 100,000 population aged 15 
or older in 2009. This corresponds to an annual increase 
of 3.1  %. After 2009, the number of SUD treatments 
remained constant until 2013. From 2000 to 2013, hos-
pital treatments of alcohol-related liver diseases (ICD-10, 
K70) increased among men by 2.4 % annually and among 
women by 1.7 % annually. With regards to non-alcoholic 
liver diseases (ICD-10, K74), after a decrease from 2000 
to 2009 (males: −3.2 % annually, females: −1.9 % annu-
ally) numbers remained unchanged from 2009 to 2013.
Discussion
Three main results were found: first, liver cirrhosis mor-
tality decreased starting in 1977 among males and in 
1969 among females. This trend was accompanied by 
decreases in alcohol consumption beginning in 1977. 
Second, these results were also accompanied by decreases 
in consumption of cigarette equivalents starting in 1972. 
Third, liver cirrhosis mortality decreased whereas the 
number of SUD treatments and hospital treatments for 
alcohol-related liver disease increased.
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The reduction in liver cirrhosis mortality is similar to 
trends found in other European countries. Data from 
other countries have also revealed a decrease in liver cir-
rhosis mortality since the mid-1970s [2]. This trend has 
been confirmed in additional countries outside of Europe 
[1] including the United States [3]. This alignment sug-
gests two potential causes for the reduction in liver cir-
rhosis mortality: a decrease in alcohol consumption and 
improvement in treatments.
The decrease in pure alcohol consumption over the 
course of 37  years from 16.62 liters consumed annually 
per resident aged 15 or older to 11.13 liters consumed 
annually is accompanied by a decrease in liver cirrhosis 
mortality of approximately half: from 51.4 per 100,000 
male residents aged 15 or older in 1976  to 26.2 in 2013 
and from 21.4 per 100,000 female residents aged 15 or 
older in 1976 to 12.3 in 2013. Earlier evidence showed 
simultaneous changes in the relationship between alco-
hol consumption and liver cirrhosis mortality in a dose–
response relationship pattern [7].
Potential reasons for the decrease in alcohol consump-
tion might include public health activities aiming to 
reduce alcohol consumption in the general population, 
further changes in social norms with regards to alco-
hol consumption, changes in the economy, mechanisms 
of the beverage market, changes in educational attain-
ment, and reductions in tobacco consumption. Public 
health activities designed to reduce alcohol consumption 
did not take place in a way that might be strong enough 
to make changes. However, drinking norms may have 
changed over time, e.g., the acceptability of drinking 
and driving. Alcohol-free driving was advertised pub-
licly. Additionally, media covering other countries with 
strict alcohol policies may have had an influence. Gen-
eral health-related norms may also have become more 
influential in reducing alcohol consumption. An eco-
nomic recession in 1967 may have added to the decrease 
in alcohol consumption during this time period [cf. 16, 
17]. The increase in the proportion of people attaining 
the highest level of education may have contributed to 
improved health consciousness and decreased alcohol 
consumption. The rate of those with 12 or more years 
of education among the female population at age 19 was 
3.1 % in 1950 and 37.7 % in 2013; among men, the rate 
of those with 12 or more years of education was 6.1 % in 
1950 and 29.8 % in 2013 [18, 19].
The finding that the decline in smoking started 5 years 
earlier than alcohol consumption and liver cirrhosis 
mortality suggests an indirect and direct effect of smok-
ing on the decrease in liver cirrhosis mortality may have 
been active. The presence of indirect effects is supported 
by evidence concerning alcohol drinking and tobacco 
smoking [10, 20]. The probability of alcohol dependence 
increases as more cigarettes per day are smoked [21]. If 
tobacco smoking becomes less prevalent, the “appetite” 
for alcohol may decrease [21, 22]. A direct link between 
tobacco smoking and liver cirrhosis is also suggested 
by evidence. Cohort data revealed that tobacco smok-
ing may increase the risk of liver cirrhosis independent 
of the influence of alcohol [11, 12, 23, 24]. Even among 
those who consumed less than 7 drinks per week, female 
current smokers had a higher risk for liver cirrhosis than 
non-smokers [12]. Animal studies suggest independent 
associations between tobacco smoking and liver cirrhosis 
[10, 25].
Improvements in SUD treatments might be an addi-
tional reason for the decrease in liver cirrhosis over time. 
In Germany, the number of facilities for treating alcohol 
dependence increased steadily since 1982. However, data 
on the adult general population revealed that only 22.8 % 
of alcohol dependent subjects utilized this treatment 
[26]. Among those who had taken part in specialized 
alcohol treatment, no additional subjects had survived 
14  years after the baseline interview than among those 
who did not utilize specialized alcohol treatment services 
[26]. These findings do not speak in favor of SUD treat-
ment as contributing significantly to the decrease in liver 
cirrhosis.
The increase in hospital treatments for alcohol-related 
liver disease since 2000 might be of some relevance for 
explaining the decrease in liver cirrhosis mortality. One 
reason for the increase in hospital treatments might be 
increased detection rates in primary medical care [27]. 
Fewer individuals may have gotten to a stage of severe 
impairment, a stage in which cirrhosis develops. Treat-
ments and secondary prevention of liver disease have also 
likely improved [28] as have the survival rates of patients 
with liver cirrhosis [29, 30]. However, data from the UK 
revealed no progress in survival rates during almost five 
decades through 1999 [31, 32].
Fig. 1 Trends of liver cirrhosis mortality, alcohol and tobacco sales 
and alcohol treatment
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The strengths of the present study include the time 
span of 62  years covered by the data for liver cirrho-
sis mortality and alcohol and tobacco sales and the data 
being largely free of bias except the diagnosis of liver cir-
rhosis as the cause of death. Limitations include that liver 
cirrhosis may have been underestimated. For example, 
cases of death that occurred outside the hospital may not 
have been captured. Data from a previous study revealed 
that less than half of liver cirrhosis deaths detected by 
autopsy had been declared in mortality statistics [33]. 
Additionally, the proportion of alcohol-related liver cir-
rhosis among all liver cirrhosis cases may have been 
reduced over time. Changes in liver cirrhosis rates result-
ing from the obesity epidemic may increase the propor-
tion of non-alcoholic fatty liver disease [34].
Conclusions
Liver cirrhosis mortality among males and alcohol and 
tobacco consumption started to decline within 5 years of 
one another. The data support that in addition to reduced 
alcohol consumption reductions in tobacco smoking may 
have added to decreases in liver cirrhosis mortality over 
time. Although the number of specialized treatments 
for SUD increased during this time period as well, we 
could not confirm that it significantly contributed to the 
decrease in liver cirrhosis mortality.
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